Drug Profile
PF 6282999
Alternative Names: PF-06282999; PF-6282999Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pfizer
- Class Cardiovascular therapies
- Mechanism of Action Peroxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute coronary syndromes
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Acute coronary syndromes(In volunteers) in USA (PO, Tablet)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute coronary syndromes(In volunteers) in Belgium (PO, Suspension)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute coronary syndromes(In volunteers) in Belgium (PO, Tablet)